These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3000657)

  • 1. Renin-like activity in vascular tissue of DOC-salt hypertensive rats.
    Grinspon DO; Basso N; Ruiz P; Mangiarua E; Taquini AC
    Clin Exp Hypertens A; 1985; 7(9):1269-82. PubMed ID: 3000657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain renin-angiotensin system and the development of DOC-salt hypertension.
    Basso N; Ruiz P; Kurnjek ML; Cannata MA; Taquini AC
    Clin Exp Hypertens A; 1985; 7(9):1259-68. PubMed ID: 3907896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-like activity in the rat brain during the development of DOC-salt hypertension.
    Basso N; Ruiz P; Mangiarua E; Taquini AC
    Hypertension; 1981; 3(6 Pt 2):II-14-7. PubMed ID: 7028611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y; Doyle AE
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma kinin concentration in deoxycorticosterone-salt hypertension.
    Nakagawa M; Nasjletti A
    Hypertension; 1988 May; 11(5):411-5. PubMed ID: 3284820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I; Brown MJ; Dollery CT
    Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Area postrema ablation and vascular reactivity in deoxycorticosterone-salt-treated rats.
    Bruner CA; Mangiapane ML; Fink GD; Webb RC
    Hypertension; 1988 Jun; 11(6 Pt 2):668-73. PubMed ID: 3391678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
    Chen K; Zhang X; Dunham EW; Zimmerman BG
    Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
    Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
    J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
    Arvola P; Ruskoaho H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchangeable sodium in DOC-salt and post-DOC-salt hypertension in rats.
    McAreavey D; Brown WB; Murray GD; Robertson JI
    J Hypertens; 1985 Jun; 3(3):275-9. PubMed ID: 3894516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme labeled with [3H]captopril. Tissue localizations and changes in different models of hypertension in the rat.
    Wilson SK; Lynch DR; Snyder SH
    J Clin Invest; 1987 Sep; 80(3):841-51. PubMed ID: 3040809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q; Touyz RM; Schiffrin EL
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensinogen concentration in the cerebrospinal fluid in different experimental conditions in the rat.
    Ruiz P; Basso N; Grinspon D; Mangiarua E; Cannata MA
    Hypertension; 1983; 5(6 Pt 3):V29-33. PubMed ID: 6360880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular renin-like activity in aorta and mesenteric artery of the rat.
    Grinspon D; Basso N; Ruiz P; Mangiarua E; Taquini AC
    Arch Int Physiol Biochim; 1986 Apr; 94(1):1-6. PubMed ID: 2425764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular changes associated with deoxycorticosterone-NaCl-induced hypertension.
    Lee RM; Richardson M; McKenzie R
    Blood Vessels; 1989; 26(3):137-56. PubMed ID: 2790213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of vasopressin and other pressor systems to DOC-salt hypertension in rats.
    Mento PF; Wang HH; Sawyer WH
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):58-63. PubMed ID: 6694969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in vascular ionic composition at different stages of DOC-salt hypertension in the rat.
    Villamil MF; Amorena C; Ponce J; Müller A; Taquini AC
    Clin Sci (Lond); 1981 Jul; 61(1):115-8. PubMed ID: 7249551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.